Details of the Drug

General Information of Drug (ID: DMSJWTE)

• Drug Name: OKI 179

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]

• Drug Type: Small molecular drug
• Cross-matching ID: TTD ID: DZU72C

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Histone deacetylase (HDAC)	TTBH0VX	NOUNIPROTAC	Inhibitor	[2]

References

• [1] ClinicalTrials.gov (NCT03931681) A Study of OKI-179 in Patients With Solid Tumors. U.S. National Institutes of Health.
• [2] Clinical pipeline report, company report or official report of OnKure Therapeutics.